Weight loss drug ‘Ozempic’ approved in India: Key health benefits and risks

India has officially approved Ozempic (semaglutide), a once-a-week injection for adults with type 2 diabetes, which also aids in weight loss. This GLP-1 receptor analogue helps control blood sugar, offers cardiovascular protection, and supports healthier eating habits. While promising for India’s rising diabetes rates, users should be aware of potential side effects.